Andrew Almond
Director/Miembro de la Junta en Imperagen Ltd. .
Perfil
Andrew Almond is the founder of C4X Discovery Ltd.
(founded in 2008) and C4X Discovery Holdings Plc (founded in 2008), where he held the title of Director & Chief Technology Officer (2008-2013) and Chief Technical Officer (inactive).
He is currently a Director at Imperagen Ltd.
(since 2021).
Dr. Almond obtained a doctorate degree from The University of Manchester and an undergraduate degree from The University of Edinburgh.
Cargos activos de Andrew Almond
| Empresas | Cargo | Inicio |
|---|---|---|
Imperagen Ltd.
 Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Director/Miembro de la Junta | 23/11/2021 |
Antiguos cargos conocidos de Andrew Almond.
| Empresas | Cargo | Fin |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Fundador | - |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Fundador | - |
Formación de Andrew Almond.
| The University of Edinburgh | Undergraduate Degree |
| The University of Manchester | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Imperagen Ltd.
Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Commercial Services |
- Bolsa de valores
- Insiders
- Andrew Almond
